EUVIMEDEUVIMED entdecken
EvaluationsstudieVergleichsstudie

Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples

Jenni Horsma-Heikkinen iD, Anu Pätäri-Sampo, Tanja Holma, Annika Nevalainen, Nathalie Friberg, Hanna Jarva, Raisa Loginov, Jenni Antikainen

APMIS · 2025

DOI: 10.1111/apm.13483 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift APMIS, 2025. Verfasst von Jenni Horsma-Heikkinen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Feces, Helicobacter pylori, Helicobacter Infections, Sensitivity and Specificity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: HUS Diagnostic Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate detection of Helicobacter pylori and its antimicrobial resistance is essential for eradication of the infections. The aim of this study was to compare five different CE‐IVD marked assays in detection of H. pylori from 268 clinical stool samples. Samples were considered positive for H. pylori when at least three of the five tests were positive. Amplified IDEIA Hp StAR (Oxoid) and Premier Platinum HpSA PLUS (Meridian Bioscience Inc.) assays showed sensitivity of 100% [95% CI (confidence interval): 87–100] and LIAISON® Meridian H. pylori SA (DiaSorin) of 83.3% (95% CI: 66–93). Specificities of the assays were 94.5% (95% CI: 91–97), 95.4%; (95% CI: 92–97), and 97.1% (95% CI: 94–99) respectively. Amplidiag® H. pylori + ClariR (Mobidiag) assay showed 93.3% (95% CI: 78–99) and Allplex™ H. pylori & ClariR Assay (Seegene Inc.) 36.7% (95% CI: 22–55) sensitivity, while specificity of both was 97.9% (95% CI: 95–99). The Amplidiag® and Allplex™ assays concordantly detected clarithromycin resistance in positive for H. pylori samples. The Amplidiag® assay showed the highest accuracy, namely 97.4% (95% CI: 95–99). These data provide helpful information for planning laboratory diagnostics of H. pylori and detection of clarithromycin resistance from stool samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesHelicobacter pyloriHelicobacter InfectionsSensitivity and SpecificityHumansAdultFemaleMiddle AgedMaleAgedAdolescentYoung AdultChildMolecular Diagnostic TechniquesChild, PreschoolAged, 80 and over

Stichwörter der Autor:innen

Helicobacter pyloriantigen testclarithromycinmolecular diagnosticsstool sample

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Jenni Horsma-Heikkinen

Förderung

  • HUS Diagnostic Center

Zitieren

APA

Horsma-Heikkinen, J., Pätäri-Sampo, A., Holma, T., Nevalainen, A., Friberg, N., Jarva, H., Loginov, R., & Antikainen, J. (2025). Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples. APMIS. https://doi.org/10.1111/apm.13483

Vancouver

Horsma-Heikkinen J, Pätäri-Sampo A, Holma T, Nevalainen A, Friberg N, Jarva H, et al. Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples. APMIS. 2025. doi:10.1111/apm.13483

BibTeX
@article{HorsmaHeikkinen2025,
  author = {Horsma-Heikkinen, Jenni and Pätäri-Sampo, Anu and Holma, Tanja and Nevalainen, Annika and Friberg, Nathalie and Jarva, Hanna and Loginov, Raisa and Antikainen, Jenni},
  title = {Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples},
  journal = {APMIS},
  year = {2025},
  doi = {10.1111/apm.13483}
}
Kostenlos starten →